Water Island Capital’s Cardlytics CDLX Stock Holding History

Water Island Capital’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,795	Closed	-$8.05M	–	98
2020 Q4	$8.05M	Buy	+22,795	New	+$24.3M	0.57%	32

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Water Island Capital's CDLX Position: Q1 2021 in Review

Water Island Capital sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 22,795 shares — an estimated $8.05M sold.

Water Island Capital first reported a position in CDLX in Q4 2020 and held it in 1 quarter. The position peaked at $8.05M in Q4 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

Water Island Capital reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
Water Island Capital sold 22,795 Cardlytics shares in Q1 2021, an estimated $8.05M.
Water Island Capital first reported a position in Cardlytics in Q4 2020 and held it in 1 quarter.
Water Island Capital's Cardlytics position peaked at $8.05M in Q4 2020.
204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Water Island Capital's 13F filing for Q1 2021, filed 13 May 2021.